Annual COVID-19 booster? FDA cliff notes
A consequential meeting took place at the FDA today. Their external scientific committee—called VRBPAC—met to discuss the national plan for COVID-19 boosters going forward. They essentially needed to answer one question: Do we simplify the COVID-19 vaccine approach in the U.S. and, if so, how?
Here are your cliff notes.
The challenge
No one has a crystal…
